Safeguard Scientifics Q4 and Full-Year Financial Results Recap
This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5…
Posted by
This morning, we announced our fourth quarter and full-year 2011 financial results. Consolidated net loss for the three months ended December 31, 2011 was $24.5…
Posted by
The latest report from MoneyTree and the National Venture Capital Association shows that corporate venture capitalists (CVCs) increased investments over the past three years. In…
Posted by
According to a 2011 IDC Digital Universe study sponsored by EMC, the amount of global data generated annually is doubling every two years and was…
Posted by
The past two weeks were brought to you by the letters IPO. From Facebook’s well-documented filing to this week’s IPO price cuts, a flurry of…
Posted by
Sunday’s Super Bowl was the most-watched event in the history of television, but more telling than the number of viewers was the way in which…
Posted by
Welcome to the inaugural blog post for Safeguard Scientifics’ Q&A Series, featuring our partner company CEOs! We believe that our blog is a perfect medium…
Posted by
Last year was a strong year for venture capital, according to the MoneyTree report issued by the National Venture Capital Association. Investments grew 22 percent…
Posted by
In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…
Posted by
As 2011 comes to a close, it offers us an opportunity to look back at the major milestones and key events of the year. While…
Posted by